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Epithelial–mesenchymal transformation (EMT), the process by which epithelial cells are converted into motile, invasive mesenchymal
cells, is critical to valvulogenesis. Transforming growth factor-h3 (TGF-h3), an established mediator of avian atrioventricular (AV) canal
EMT, is secreted as a latent complex. In vitro, plasmin-mediated proteolysis has been shown to release active TGF-hs from the latent
complex. Annexin II, a co-receptor for tissue plasminogen activator (tPA) and plasminogen, promotes cell-surface generation of the serine
protease plasmin. Here, we show that annexin II-mediated plasmin activity regulates release of active TGF-h3 during chick AV canal EMT.
Primary embryonic endocardial-derived cells express annexin II which promotes plasminogen activation in vitro. Incubation of heart explant
cultures with either a2antiplasmin (a2AP), a major physiological plasmin inhibitor, or anti-annexin II IgG, blocked EMT by f80%, and
50%, respectively. Anti-annexin II IgG-mediated inhibition of EMT was overcome by the addition of recombinant TGF-h3. Upon treatment
with anti-annexin II IgG or a2AP, conditioned medium from heart explant cultures showed absence of the active fragment of TGF-h3 by
Western blot analysis and a f50% decrease in TGF-h specific bioactivity. Our results suggest that annexin II-mediated plasmin activity
regulates the release of active TGF-h during cardiac valve development in the avian heart.
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Epithelial–mesenchymal transformation (EMT), a cen-
tral mechanism in organogenesis, occurs at precise times
and locations during embryogenesis. During EMT, defined
subsets of polarized epithelial cells undergo a phenotypic
switch and become detached, motile, and invasive mesen-
chymal cells (Hay, 1995). These cells then migrate through
extracellular matrix (ECM) to either nearby or remote
locations before committing to a final site-specific fate. At
the cellular level, EMT occurs as the consequence of a series
of membrane signaling events that result in the sequential
activation and repression of specific genes (Hay and Zuk,
1995). It is known that members of transforming growth
factor-beta (TGF-h) family can modulate EMT in several0012-1606/$ - see front matter D 2003 Elsevier Inc. All rights reserved.
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responses in EMT involve a host of events, including down-
regulation of cell adhesion molecules (Cano et al., 2000)
and up-regulation of extracellular proteases (Lochter et al.,
1997).
Cardiac development is characterized by a series of step-
wise EMTs, which include the formation of endocardial
cushions, the primordia of post-natal heart valves and
septae. Between developmental stages 9 and 14 by Ham-
burger–Hamilton classification (Hamburger and Hamilton,
1992), the heart segments (atrioventricular (AV), right
ventricle (RV), left ventricle (LV), and conotruncus outflow
tract (OT)) emerge along the antero-posterior axis of the
heart tube (de la Cruz et al., 2001). Each segment is defined
by two concentric layers of epithelium, the outer myocar-
dium and the inner endocardium, which are separated by a
continuous acellular zone of ECM, called the ‘‘cardiac
jelly’’ (Little and Rongish, 1995). Starting at about stage
13+, myocardium-derived inductive signals such as bone
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protein (Rezaee et al., 1993) initiate the transformation of
target endocardial cells of the AV and OT regions. By early
stage 15, some endocardial cells show evidence of ‘‘activa-
tion’’ (Bolender et al., 1981) that progresses by stage 16–17
to the phenotypic features characteristic of ‘‘transformation’’
(Markwald et al., 1975). These transformed cells then
invade the adjacent ECM giving rise to the AV cushion
mesenchyme (Markwald et al., 1977). Although the molec-
ular basis of avian AV canal EMT is only partially under-
stood, the cellular changes require the separate and
coordinated actions of TGF-h2 and TGF-h3 (Boyer et al.,
1999; Camenisch et al., 2002; Potts et al., 1991). In
addition, TGF-h3 sustains and amplifies EMT by a positive
feedback effect on neighboring primed endocardial cells
(Ramsdell and Markwald, 1997).
All three isoforms of TGF-h (TGF-h1, TGF-h2, and
TGF-h3) are secreted as part of a latent complex (Annes et
al., 2003). The secreted complex consists of active TGF-h, a
25-kDa homodimeric protein derived from the C-terminal
portion of pro-TGF-h. Active TGF-h3 remains non-cova-
lently associated with an N-terminal remnant portion called
latency associated peptide (LAP) (Munger et al., 1997).
LAP is linked by disulfide bonds to a third protein, latent
TGF-h binding protein (LTBP) (Wakefield et al., 1988),
which directs the entire complex (TGF-h, LAP, LTBP) to
ECM (Taipale et al., 1994). In order for TGF-h to bind to its
surface receptors, active TGF-h must be dissociated from
LAP, an event that requires a regulated series of extracellular
steps (Annes et al., 2003; Leitlein et al., 2001; Lyons et al.,
1988).
The role of the serine protein plasmin in the release of
active TGF-h has been documented in both in vitro co-
culture systems (Sato and Rifkin, 1989) and in vivo
(Barcellos-Hoff et al., 1995). Although plasmin is produced
following blood coagulation by activation of fibrin-bound
plasminogen by tissue plasminogen activator (tPA) or
urokinase (uPA) (Collen and Lijnen, 1986), and results in
the breakdown of the fibrin clot, its broad in vitro speci-
ficity has suggested a role in the degradation of ECM
proteins as well as the activation of growth factors (Rifkin
et al., 1999). In recent years, the concept that plasminogen
activated on the cell surface is protected from inhibitors, has
led to the study of cell surface fibrinolytic receptors such as
uPAR (uPA receptor) (Plesner et al., 1994), and annexin II
(Hajjar, 1995), and placed the fibrinolytic pathway in the
context of the cell–matrix interactions that occur during
development.
Annexin II is a 36-kDa member of the annexin family of
calcium- and phospholipid-binding proteins that have a
prototypical structure consisting of a conserved carboxy-
terminal ‘‘core’’ domain and a variable amino-terminal
‘‘tail’’domain (Hajjar and Krishnan, 1999). In previous
studies using human umbilical vein endothelial cells, we
demonstrated the enhanced catalytic efficiency of plasmin-
ogen activation by the colocalization to cell surface annexinII of both plasminogen and tPA (Cesarman et al., 1994;
Hajjar et al., 1994). The expression of annexin II has also
been shown to be developmentally regulated in the rat
(McKanna and Cohen, 1989) and mouse central nervous
systems (Hamre et al., 1995), as well as the chick limb bud
(Carter et al., 1986) where EMT is known to occur (Haines
and Currie, 2001).
Several studies have examined the contributions of the
plasminogen/plasmin system to cell migration and tissue
remodeling during development of the cardiovascular and
central nervous systems (reviewed by Thery and Stern,
1996). uPA activity (McGuire and Orkin, 1992) and matrix
metalloproteinase-2 expression (Alexander et al., 1997)
have been observed in the endocardium during chick heart
AV cushion formation. Previous studies have focused on the
role of extracellular proteolytic activity in the cell migration,
tissue invasion, and ECM remodeling processes of AV canal
EMT (McGuire and Alexander, 1993; Song et al., 1999).
Few studies, however, have addressed the activation of
TGF-h during embryogenesis. Avian cranial neural crest
cells secrete and activate latent TGF-h in vitro in the
presence of plasminogen (Brauer and Yee, 1993). Latent
TGF-h is abundant in the ECM of embryonic chick hearts,
whereas active TGF-h has a much more limited distribution
(Ghosh and Brauer, 1996). A study examining the activation
status of TGF-h2 during early stages of chick heart devel-
opment revealed distinct, stage-specific differences in the
presence of active TGF-h. These results imply that TGF-h3
activation may be critical for regulating TGF-h3 function
during avian heart valve formation (McCormick, 2001).
The present study was designed to determine whether
localized cell surface plasmin proteolysis regulates the
activation of sequestered TGF-h. Our results show that the
fibrinolytic receptor annexin II is present in the endocardi-
um during AV canal EMT, and that its presence correlates
with the activation of latent TGF-h and endocardial cell
transformation in avian AV canal EMT.Materials and methods
Fertilized eggs
Fertilized pathogen-free White Leghorn chicken eggs
(SPAFAS) were placed in an air-circulating incubator at
36jC upon receipt. Incubation times were calculated from
the initiation of incubation. Embryos were staged according
to the Hamburger–Hamilton system (Hamburger and Ham-
ilton, 1992).
Western blot analyses
Annexin II
Annexin II protein expression was analyzed from hearts
of chick embryos (stage 13–18) pooled in phosphate-
buffered saline (PBS, pH 7.2). Hearts were homogenized
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5 mM EGTA, pH 7.5) at 21jC. Homogenates were further
incubated at 100jC for 10 min, cooled to 21jC, and
centrifuged (12,000  g, 10 min). Protein content of super-
natants was estimated using the BCA (Pierce) method.
Samples (30 Ag total protein) were resolved under reducing
conditions on 12.5% SDS-polyacrylamide gels and trans-
ferred to nitrocellulose membranes (Bio-Rad). Membranes
were blotted with polyclonal anti-annexin II IgG (3 Ag/ml,
raised against the tail peptide sequence of annexin II,
Covance), in 2% non-fat dry milk in Tris-buffered saline
(TBS, 25 mM Tris base, 150 mM NaCl, pH 7.5) containing
0.3% (v/v) Tween 20 (TBS-T). After washing, blots were
incubated with anti-rabbit IgG–HRP conjugate (1:2000)
and developed using the ECL chemiluminescence detection
system (Amersham Pharmacia Biotech). The blot was
reprobed with monoclonal anti-smooth muscle alpha actin
IgG (Sigma) (Skalli et al., 1986), to verify equal loading of
protein.
Active TGF-b
To assay the active fragment of TGF-h3, 15–20 chick
hearts (stage 15–16 embryos) were pooled and cultured in
60 Al of serum-free M199 containing ITS (5 Ag/ml insulin,
5 Ag/ml transferrin, and 5 ng/ml selenium; Life Technolo-
gies, M199-ITS). Hearts were treated with anti-annexin II
IgG, pre-immune IgG (100 Ag/ml), or a2antiplasmin
(a2AP, 75 nM), and cultured for 48 h, during which time
they continued to contract rhythmically, confirming their
viability throughout the culture period. Identical, explant-
free samples served as controls. The conditioned medium
was analyzed by 15% SDS-PAGE/Western blot, using
affinity purified biotinylated IgG directed against chick
active-TGFh-3 (0.25 Ag/ml, R&D). Streptavidin–HRP
conjugate (1:3000, Amersham Pharmacia Biotech) was
used to detect the reactive protein bands using the ECL
chemiluminescence detection system (Amersham Pharma-
cia Biotech).
Western blot data were scanned and saved as digital
images using Adobe Photoshop version 4.0.1 (Adobe
Systems).
Northern blot analyses
Embryonic chick hearts (stages 13–18) were isolated as
described for Western blot analysis and homogenized by
sequential expulsion through 18- and 25-gauge needles.
Total RNA was extracted using Trizol reagent (Life Tech-
nologies). RNA was quantified spectrophotometrically, re-
solved on a 1.2% RNAse-free formaldehyde–agarose gel
and transferred to Zetaprobe nylon membranes (Bio-Rad) as
described previously (Chacko et al., 1998). The membranes
were prehybridized (Quick-Hyb, Stratagene, 68jC, 1 h),
hybridized (68jC, 18 h) with a 32P-labeled antisense ribop-
robe derived from bases 1–876 of chick annexin II cDNA
(Dr. Volker Gerke, University of Muenster, Germany), andsubjected to autoradiography. The blots were stripped and
reprobed with a chick GAPDH probe (Dr. Takashi Mikawa,
Weill Medical College of Cornell University) to confirm
equal loading. The autoradiograms were scanned and saved
as digital images using Adobe Photoshop version 4.0.1
(Adobe Systems).
Whole mount in situ hybridization
In situ hybridization was carried out essentially as
described (Stern, 1998). Embryos were harvested in
Ca2+-, Mg2+-free PBS (CMF-PBS, pH 7.4) at the indicated
times, fixed in freshly prepared 4% paraformaldehyde in
CMF-PBS containing 2 mM EGTA (4jC, 18 h), and
transferred to absolute methanol (20jC). The embryos
were rehydrated through graded methanols to CMF-PBS
and 0.1% Tween 20, and treated with proteinase K (10 Ag/
ml) according to a pre-optimized schedule based on the
stage of the embryo. Embryos were refixed in 4% PFA
containing 0.1% glutaraldehyde (20 min, 21jC), washed,
and hybridized with sense or antisense riboprobes (1 Ag/ml,
18 h, 70jC for probes >500 bp and 65jC for probes
<350 bp). Digoxygenin-labeled single-strand RNA probes
were prepared using a DIG-RNA labeling kit and detected
with anti-digoxygenin alkaline phosphatase antibody
(Roche Diagnostics). The original 876-bp chick annexin II
probe was cloned into the EcoRI site of pBluescript (pBS),
providing a construct that could be transcribed in either the
sense or antisense direction. Two additional riboprobes (530
and 330 bp) were generated and used as non-overlapping
antisense constructs. Whole mount embryos were fixed in
4% formaldehyde/0.1% glutaraldehyde in PBS containing
0.1% Tween (pH 7.4), and embedded in paraffin. Serial
10 Am cross sections were obtained, mounted, and exam-
ined by light microscopy.
Chick endocardial cell culture
Collagen lattices were polymerized using type-1 rat-tail
collagen (Collaborative Biomedical Products, Bedford, MA)
by addition of phenol red containing alkalinized 10 M199
(1 N NaOH, colorimetric endpoint) at 37jC. Upon poly-
merization, the gels were hydrated in M199-ITS containing
2% chick serum before the addition of the heart explants
(5% CO2, 37jC, 1 h). AV and OT regions were micro-
dissected from stage 15–16 hearts under aseptic conditions,
cut longitudinally, and placed endocardial side down on the
surface of hydrated collagen lattices (5% CO2, 37jC)
(Runyan and Markwald, 1983).
Outgrowth of endocardial-derived cells (EDC) was
observed after 10–12 h while the explanted hearts con-
tinued to beat. At 48–72 h, the beating hearts were
removed with fine forceps and surface migrated cells
passaged with 0.025% trypsin onto six-well plates coated
with collagen (50 Ag/ml). In some experiments, quail em-
bryo (Coturnix coturnix japonica) explants were established
in parallel.
Fig. 1. Temporal expression profile of annexin II mRNA and protein in stage 13–18 embryonic chick hearts. (A) Northern blot. Total RNA from pooled,
isolated hearts was loaded in separate lanes according to serial stage-wise groupings, and probed with an 876-bp antisense riboprobe. (B) Western blot. Four
percent SDS-extracted proteins were probed with polyclonal anti-annexin II IgG. Human umbilical endothelial cell lysate, known to express annexin II (Hajjar
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AV canal explants (stages 15–16) were placed on colla-
gen gels and cultured for 48 h as described above. For
immunochemical detection of annexin II and smooth muscle
alpha-actin (SMA) (Nakajima et al., 1999), explants were
fixed in 2% PFA for 30 min at 37jC. After extensive
washing with PBS, explants were treated with rabbit anti-
annexin II IgG or pre-immune IgG (50 Ag/ml, each) and
mouse anti-SMA IgG (25 Ag/ml, Sigma) in PBS/1% bovine
serum albumin (BSA)/0.1% Triton X-100. Similarly,
explants fixed in 1% PFA were treated with mouse anti-
procollagen type 1 antibody (mouse monoclonal, dilution
1:1, from the Developmental Studies Hybridoma Bank,
University of Iowa) in the same buffer. Primary antibody
incubations were carried out overnight at 4jC. Secondary
antibodies were Alexa Fluor 546 labeled anti-rabbit or
Alexa Fluor 488-labeled anti-mouse IgG (1:100 dilution
each). Stained explants were viewed with a Zeiss LSM510
laser-scanning confocal microscope.
Confluent primary EDC cultures of chick and quail
origin, as described above, were washed with incubation
buffer, IB, consisting of Hepes-buffered saline (HBS:
140 mM NaCl, 4 mM KCl, 10 mM HEPES, pH 7.4)
containing 1 mM MgCl2, 3 mM CaCl2, and fixed in 4%
formaldehyde (37jC, 30 min). After washing thrice with IB,
cells were blocked with 1% BSA in HBS (30 min, 37jC).
Chick cells were incubated with anti-annexin II IgG (10 Ag/
et al., 1986) was used as control (Con).ml, 4jC, 18 h). To confirm derived origin of cells, quail cells
were incubated with anti-QH1 IgG (Developmental Studies
Hybridoma Bank, at 1:10, 4jC, 18 h) (Pardanaud et al.,
1987). In both cases, appropriate controls were used, pre-
immune IgG (10 Ag/ml, 4jC, 18 h) for chick cells, and NS1
(Developmental Studies Hybridoma Bank, 1:10, 4jC, 18 h)
for quail cells. Cells were washed with 1% BSA in HBS and
incubated with secondary antibody (anti-rabbit IgG–FITC or
anti-mouse IgG–FITC at 1:400 dilutions, ICN, 30 min,
21jC) before examination by fluorescence microscopy.
Plasmin generation/inhibition assay
Primary chick EDC were grown to confluence (0.5 
106 cells/well) in six-well plates (Costar). Cells were
washed with IB containing 0.2% BSA (w/v, IB-2), and
incubated with 100 nM glu-plasminogen (PLG, American
Diagnostica) in IB-2 (1 h, 21jC), and washed thrice with
IB-2 (5 min/wash). Cells were incubated with 10 nM tPA
(American Diagnostica) and 125 AM of a fluorogenic
plasmin substrate (D-val-leu-lys-aminofluormethylcou-
marin, AFC-81, Enzyme Systems Products). Fluorescence
was analyzed at 3–6 min intervals (excitation wavelength
400 nm, emission wavelength 505 nm), over a 30-min time
period, using Spectra Max Gemini XS fluorometer (Mo-
lecular Devices). Rates of plasmin generation were plotted
as relative fluorescence units (RFU)/min2 (Jacovina et al.,
2001).
Fig. 2. Localization of annexin II expression by in situ hybridization. (A) Composite view of mid-thorax transverse section of a stage 15 chick embryo following
whole mount in situ hybridization. Positive staining of notochord (jagged arrow) and endocardium (arrows) are shown (original magnification 100). (B)
Higher magnification view of tubular heart (original magnification 200). (C) Higher magnification view of wall of tubular heart (original magnification
400).
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AV segments of hearts from stage 15–16 embryos were
placed endocardial side down on the surface of hydrated
collagen gels (four to five explants per collagen gel consti-
tuted in 12-well plates, Costar) (Runyan and Markwald,
1983). After allowing the explants to attach (6–8 h), 300 Al
complete medium (M199-ITS, 2% chick serum) was added
and the explants cultured for 48 h (5% CO2, 37jC). In some
experiments, cultured explants were treated with a2AP
(75 nM), and others with polyclonal anti-annexin II IgG
or pre-immune IgG (100 Ag/ml), with and without recom-
binant TGF-h3 (rTGF-h3, R&D Systems, 10 ng/ml).
Confocal microscopy
Explants were gently rinsed with PBS and fixed in 4%
formaldehyde in PBS (30 min, 37jC). After rinsing,
explants were stained with propidium iodide without
RNAse treatment to allow assessment of cell shape (spindle
vs. spherical shape). The gels were subjected to confocal
optical sectioning at 12 Am intervals (estimated average
major axis of spindle-shaped cells) beginning with the
surface of the gel and progressing through the depth of
the gel until cells were no longer visible. Confocal images
were acquired with a Zeiss LSM510 laser-scanning confocal
microscope. Post-acquisition image analysis was performedwith MetaMorph imaging software (Universal Imaging
Corp.), and images were prepared for publication using
Adobe Photoshop (Pierini and Doering, 2001). All images
from a single explant were analyzed as a set, and cells were
sorted according to ‘‘elliptical form factor’’ (EFF), the
length ratio of major to minor axes. By visual examination,
it was determined that an EFF of 1 indicated a spherical
shape, while an EFF >2.5 correlated with spindle-shaped
cells. For each set of planar images generated by a single
heart explant, spindle cells were expressed as a percent of
the total number of cells counted.
TGF-b3 bioassay
To quantify latent TGF-h3 activation by embryonic chick
hearts during AV canal EMT, 25 heart explants from stage
15–16 embryos were pooled, and cultured in M199-ITS
(100 Al). These culture media contained either anti-annexin
II IgG or pre-immune IgG (100 Ag/ml). After 48 h, test
media obtained from these cultures were divided equally
(50 Al/well) and added directly to mink lung reporter cells
stably transfected with a luciferase gene under control of the
TGF-h responsive PAI-1 promoter (TMLC, Dr. D. Rifkin,
New York University Medical Center, NY). By directly
adding test media to the TGF-h reporter cells, freeze–
thawing of the samples was avoided, a process known to
induce TGF-h activation. TMLCs (0.6  105 cells/ml in
Fig. 3. Confocal analysis of expression of annexin II and SMAduring EMT in collagen gel culture model. (A) Double immunofluorescence labeling of endothelial
cell outgrowth over the gel shows expression of annexin II (red) in all cells, while SMA expression (green) was seen in the intermediate and peripheral zones of the
outgrowth. Annexin II and SMA co-expression in intermediate-peripheral zone (orange-yellow). * = heart explant. (Original magnification100.) (B) Annexin II
(red), SMA (green), and Annexin II and SMA co-expression (orange-yellow). Both endocardial cells and spindle-shaped (mesenchymally transforming) cells
present in the surface outgrowth show annexin II expression. (Original magnification 200.) (C) Spindle-shaped cells in the depth of the gel show expression of
annexin II (red), as well as SMA expression (green). (Original magnification 300.) Expression of annexin II by cultured EDCs. (D) Indirect
immunofluoroscence staining of EDC with pre-immune IgG (PI) or annexin II IgG (Anti-ann II). (Original magnification400.) (E) Western blot of chick EDC
lysates showing immunoreactivity with anti-annexin II IgG. Human umbilical vein endothelial cell lysate was used as control (Con) (Hajjar et al., 1986).
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and allowed to attach for 4 h. These wells were additionally
treated with or without anti-TGF-h IgG (R&D Systems,
15 Ag/ml) to determine specificity of TGF-h3-related re-
sponsiveness of the TMLCs. In separate wells, recombinant
chick TGF-h3 (R&D, 25 pg/ml) added to the TMLCs
served as a positive control. After 16 h, the TMLCs were
lysed and the luciferase activity was measured as described
(Abe et al., 1994; Mazzieri et al., 2000).Fig. 4. Annexin II-dependent plasminogen activation in the presence of
EDC. Primary EDCs were grown to confluence and used in a fluorogenic
plasmin generation assay. Rates of plasmin generation for EDC treated with
pre-immune IgG (PI, 20 Ag/ml), anti-annexin II immune IgG (IM, 20 Ag/
ml), or a2AP (250 nM) were measured at 3–6 min intervals over a time
course of 30 min. The results were normalized to the untreated control
(100%). To ascertain the specificity of plasminogen activation, rates of
plasmin generation were assayed with or without cells, tPA, or plasminogen
(Plg). Data shown represent mean values F SE, n = 3 separate
experiments.Results
Annexin II is expressed in the embryonic chick heart during
AV cushion formation
By both Northern and Western blot analyses, embryonic
chick hearts demonstrated the presence of the 1.2-kb
annexin II mRNA (Fig. 1A) and the 36-kDa annexin II
protein, respectively (Fig. 1B) in all stages examined (13–
18). Furthermore, in situ hybridization using a 876-bp
annexin II antisense riboprobe revealed the presence of
annexin II message, predominantly in the endocardium
and notochord of stage 15–16 embryos (Fig. 2). Strong
staining for annexin II message was noted throughout the
endocardium, including areas of the outflow and inflow
tracts, with no staining in the myocardium. A pattern of
staining identical to that seen with the 876-bp antisense
riboprobe was also observed with two non-overlapping
annexin II antisense constructs (550 and 330 bp, not
shown). Finally, in situ hybridization with a 876-bp sense
riboprobe did not show any staining (not shown), suggest-
ing that the pattern of staining noted above was highly
specific. These data show that, between stages 13 and 18, at
the time of AV cushion tissue formation in the developing
heart tube, both annexin II message and protein are
expressed in the endocardium. This implies that annexin II
is present, and available to support plasminogen activation
in the endocardium of the developing chick heart during
formation of AV cushion tissue.
EDC from heart explant cultures express annexin II
The morphology of invading mesenchymal cells into the
collagen gel lattice is similar to that observed in vivo at the
light- and electron-microscopy levels (Bernanke and Mark-
wald, 1982). Using the collagen gel culture model, we further
characterized the presence of annexin II in the developing
heart. Analysis of annexin II and SMA co-expression in heart
explants cultured on collagen gels showed that annexin II was
expressed by all cells in the outgrowth from the explant onto
the surface of the gel (Figs. 3A, B), as well as in spindle-
shaped, mesenchymal cells that had invaded the depth of the
gel (Fig. 3C). SMA expression was seen in cells toward the
intermediate and peripheral zones of the outgrowth (Figs. 3A,
B), but absent in cells in the central zone of the outgrowthclose to the heart explant. SMA expression was also noted in
invaded mesenchymal cells (Fig. 3C). Nakajima et al. (1997)
have described a similar pattern of SMA expression. This
result shows that in the primary EDC cultures, all cells
express annexin II, and that cells in the process of mesen-
chymal transformation (spindle-shaped cells) also express
SMA (Nakajima et al., 1997). In addition, expression of
annexin II is retained in invaded mesenchymal cells. Figs.
3A–C, right panels, represent co-localized images of annexin
II and SMA expression.
In addition, in primary EDC cultures from stage 15–16
chick heart explants, greater than 90% of cells showed
strong staining with polyclonal anti-annexin II IgG by
indirect immunofluorescence, while no cell-surface staining
Fig. 5. Effect of anti-annexin II IgG and a2-AP on chick AV canal EMT. Stage 15–16 explants were cultured atop collagen gels and treated without (A, B) or
with a2AP (C, D), pre-immune IgG (E, F), or anti-annexin II IgG (G, H), and examined by confocal microscopy. Surface (A, C, E, G) and deep (B, D, F, H)
views of the gels were photographed to assess the extent of invasion by transformed mesenchymal cells. Images shown are representative of five experiments.
(Original magnification 100.)
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These cells also showed the presence of annexin II by
Western blot analysis using the same polyclonal anti-
annexin II IgG (Fig. 3E). Quail cells were isolated and
propagated in an identical manner to chick EDC. Indirect
immunofluorescence using anti-QH1 antibody (Pardanaud
et al., 1987) confirmed the endocardial identity of these
quail cells (data not shown). These data strongly suggest
that the cells derived by outgrowth from embryonic stage
15–16 chick hearts were of endocardial-derived origin, and
expressed cell-surface annexin II.
Chick heart EDC support annexin II-dependent
plasminogen activation
To determine whether EDC surface annexin II supported
the activation of plasminogen, in vitro plasmin generationFig. 6. (A) EMT in collagen gel culture model. Cells were stained using propidium i
(EFF >2.5) by propidium iodide staining also expressed SMA. Similarly, cells expr
Quantitative analysis of the effect of a2AP, anti-annexin II IgG, and TGF-h3 on chi
the legend to Fig. 5. For each explant, the number of spindle-shaped cells with EFF >2
1500 cells was analyzed. The data shown represent analysis of cells from at least fi
(Med = medium alone, a2AP = a2antiplasmin, PI = pre-immune, IM = anti-annexiassays were carried out (Fig. 4).For primary EDC cultures,
we harvested surface outgrowth cells from heart explants
cultured on collagen gels, without further selection. Our
method of harvesting these cells did not allow for the
inclusion of transformed mesenchymal cells that have
invaded the gel. Nevertheless, as shown in Fig. 3, all
EDC express annexin II.
Using these primary EDC cultures, we studied cell-
surface-annexin II-mediated plasmin generation. Indeed,
embryonic chick EDC showed a 6- to 8-fold increase in
tPA-dependent plasminogen activation over a time period of
30 min, compared to an acellular control. While pre-im-
mune IgG had no effect on the rate of plasmin generation,
cell-surface plasmin production was inhibited by f60%
when treated with a polyclonal anti-annexin II IgG (raised
against the tail peptide sequence of annexin II) that specif-
ically blocks tPA–annexin II binding (Hajjar et al., 1998). 
odide and anti-SMA IgG in the same explants. Cells scored as spindle-shaped
essing procollagen type 1 had EFF >2.5. (Original magnification 200.) (B)
ck AV canal EMT. Stage 15–16 explants were treated exactly as described in
.5was expressed as a percentage of total cells. For each explant, an average of
ve separate explants established on three different days (mean F SE, n = 5).
n II IgG, rTGFh3 = recombinant TGF-h3).
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specific plasmin inhibitor. Thus, EDC-surface annexin II
can support plasminogen activation in vitro.
These data suggest that annexin II expressed on embry-
onic chick EDC may support plasmin generation in vivo.
Endocardial cell EMT is plasmin- and annexin II-dependent
To further examine the significance of endocardial ex-
pression of annexin II, stage 15 heart explants were studied
by a collagen gel EMT assay. A surface view shows
exuberant outgrowth of endothelial cells (Fig. 5A). A deep
view reveals an abundance of elongated mesenchymal cells
invading the gel (Fig. 5B). Upon treatment of explants with
a2AP, endothelial cell outgrowth is somewhat reduced (Fig.
5C), while gel invasion by mesenchymal cells is profoundly
reduced (Fig. 5D). A surface view shows normal outgrowth
of cells in the presence of anti-annexin II IgG (Fig. 5G) or
pre-immune IgG (Fig. 5E) in the culture medium. A deep
view, however, shows fewer invaded mesenchymal cells in
explants cultured in the presence of anti-annexin II IgG (Fig.
5H), whereas, heart explants cultured in the presence of pre-
immune IgG show numerous invaded spindle-shaped cells
in the depth of the gel (Fig. 5F). These spindle-shaped cells
with axes ratio >2.5 also expressed the mesenchymal cell
markers SMA (Nakajima et al., 1999) (Fig. 6A, middle
panel) and procollagen type I (Fig. 6A, right panel) (Boyer
and Runyan, 2001), and corroborate the morphological basis
of scoring mesenchymal cells in our system.
Quantitative analysis of imaging data confirmed that both
anti-annexin II IgG and a2AP inhibited EMT in vitro (Fig.
6B). The results show a 50% and f80% decrease in the
number of mesenchymal cells upon treatment with anti-
annexin II IgG and a2AP, respectively. This inhibition of
transformation to mesenchyme in the presence of anti-
annexin II IgG was rescued to level of heart explants treatedFig. 7. Effect of a2-AP and anti-annexin II IgG on release of TGF-h3 active fra
medium (Med) or medium treated with a2AP (75 nM). Non-conditioned media (N
by 12.5% SDS-PAGE and Western blot analysis using affinity purified, biotinyla
recombinant human TGF-h3 (5 ng, R&D Systems, Cat. #243-B3). (B) Hearts wer
100 Ag/ml). NCM and CM from these cultures were treated as described for Panwith pre-immune IgG, by addition of recombinant TGF-h3
(10 ng/ml, 0 h). Interestingly, the addition of recombinant
TGF-h3 to pre-immune IgG-treated heart explant cultures
did not result in an increase in number of mesenchymal cells
over the level of untreated heart explants.
Our data suggest that annexin II-mediated plasmin activ-
ity II plays a role in the conversion of endocardial cells to a
spindle-shaped mesenchymal phenotype during AV canal
EMT. Furthermore, rescue of EMT inhibition by recombi-
nant active TGF-h3, suggests, that anti-annexin II IgG-
mediated inhibition of plasmin activity may also inhibit
the activation of latent TGF-h3. This implies that annexin
II-mediated cell-surface localization of plasmin activity
could regulate the activation of latent TGF-h3 during
formation of AV cushion mesenchyme.
Activation of TGF-b3 by chick heart explants is
annexin II- and plasmin-dependent
To examine TGF-h3 generation during AV canal EMT,
medium conditioned by cultures of stage 15–16 chick
hearts was analyzed for the presence of active TGF-h3 by
Western blot analysis. Our results show that in serum-free
medium (M199/ITS) conditioned by stage 15–16 heart
explant cultures, we could easily detect thef15-kDa active
TGF-h3 fragment (Fig. 7A, lane 3). The antibody reacted
with the standard and with a band in CM that migrated
slightly behind active recombinant TGF-h3. A similar
difference in molecular weight between human and chick
active TGF-h2 has been seen previously (McCormick,
2001), probably signifying species-specific variation in
post-translational modification of TGF-h. We further exam-
ined the role of annexin II-mediated plasmin activity in
liberation of active TGF-h3, by the addition of specific
inhibitors. We found that active TGF-h3 was undetectable
in conditioned medium from hearts cultured in the presencegment. (A) Fifteen to 20 stage 15–16 hearts were cultured in serum-free
CM) from these cultures, as well as conditioned media (CM) were analyzed
ted IgG directed against chick active-TGF-h3. Control (CON) consisted of
e treated with pre-immune IgG (PI, 100 Ag/ml) or anti-annexin II IgG (IM,
el A.
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treated with pre-immune IgG showed the presence of the
active TGF-h3 fragment (Fig. 7B, lane 3). On the other
hand, medium conditioned from heart explant cultures
treated with anti-annexin II IgG failed to demonstrate the
presence of the active TGF-h3 fragment (Fig. 7B, lane 4).
Active TGF-h3 was undetectable in all the explant-free,
control samples (non-conditioned medium that had been
treated with a2AP, pre-immune, or anti-annexin II IgG).
These data suggest that release of active TGF-h3 into the
medium by stage 15–16 chick hearts requires both annexin
II and plasmin activity. As these hearts were cultured in
serum-free medium, the most likely source of plasminogen
is plasma trapped within the heart tissue. This result
suggests that annexin II-mediated plasmin proteolysis could
assist in the release of active TGF-h3 from the large latent
TGF-h complex.
To directly assess the role of annexin II in TGF-h
bioactivity, media conditioned from heart explant cultures
were generated in the presence of either anti-annexin II IgG
or pre-immune IgG. These media were collected and added
to TGF-h reporter cells (TMLCs). To ensure that the
observed luciferase activity was due to TGF-h, all TMLC
cultures were carried out in duplicate, with and without pan-
anti-TGF-h IgG. Relative luminescence generated in the
presence or absence of pan-anti-TGF-h IgG was analyzed.
Heart explants cultured in the presence of anti-annexin II
IgG showed af50% reduction of TGF-h activity compared
with heart explant cultures treated with pre-immune IgG
(Fig. 8). These data correlate with the Western blot analysis,Fig. 8. Effect of anti-annexin II IgG on generation of TGF-h bioactivity. Condition
immune IgG (PI) or anti-annexin II IgG (IM) was added, with or without anti-pa
responsive PAI-1 promoter sequence fused to a luciferase reporter. Mink cells wer
Background activity, reflected by luminescence generated in the presence of non-co
each sample condition. Recombinant chick TGF-h3 (rTGF-h3, 25 pg/ml) was e
experiments.)and imply that EDC-surface annexin II-mediated plasmin
activity is involved in the release of active TGF-h from
latency.Discussion
The formation of the four-chambered heart from a simple
tube requires precise interactions among multiple cell types,
including a sequential series of EMTs (Markwald et al.,
1996). One such transformation involving the endocardium
of the AV canal region, results in the formation of cushion
mesenchyme, which subsequently gives rise to the AV
valves. However, details of the molecular mechanisms
governing EMT are not yet fully understood.
Our work shows, for the first time, the potential role for
the cell-surface fibrinolytic receptor annexin II in this
complex process. Our results indicate that cell-surface
localization of annexin II-mediated plasmin generation
could play a role in activation of TGF-h3 during AV canal
EMT.
Several lines of evidence suggest a definite role for
specific proteases in AV cushion formation. Up-regulation
of both uPA (McGuire and Orkin, 1992) and MMP (Alex-
ander et al., 1997) activities has been noted in the endocar-
dium of the AV and OT regions of the embryonic chick
heart, implicating serine- and MMP-mediated proteolysis in
the complex cellular interactions of AV cushion develop-
ment. Other studies have localized the distribution of uPA
on cell surfaces to discrete cell–substratum and cell–celled medium (CM) from heart explant cultures (stage 15–16) treated with pre-
n TGF-h IgG to mink lung epithelial cells stably transfected with a TGF-h
e assayed for generation of luminescence reflecting specific TGF-h activity.
nditioned medium, was subtracted from the total luminescence obtained for
mployed as a positive control. (Data shown represent mean F SE, n = 3
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migration events (Pollanen et al., 1987). In addition, in vitro
analyses of uPA activity in avian AV canal EMT indicated
that the functional role of uPA in cushion cell migration did
not involve the plasminogen/plasmin system. Instead, the
authors postulated that uPA either functioned as an adhesion
receptor or was involved in signal transduction (Gorny and
Brauer, 1999). In contrast, work examining the role of
MMPs in chick heart EMT points toward the importance
of membrane-anchored proteolytic activity in tissue remod-
eling processes. Specifically, MT1-MMP, either directly, or
through its activation of proMMP-2, is required for degra-
dation of the type IV collagen barrier to migrating trans-
formed mesenchymal cells (Song et al., 2000).
The formation of endocardial cushions in the AV canal of
the rudimentary heart involves a stepwise progression of
events. Inductive signals derived from the myocardium
initiate the process of EMT in the endocardium of the AV
region. Early events of avian AV canal EMT, such as loss of
cell–cell adhesion and activation, appear to be mediated by
TGF-h2 signaling, whereas later events leading to the
conversion of endocardial cells to a mesenchymal pheno-
type, as well as invasion of, and migration through under-
lying cardiac jelly matrix are regulated by TGF-h3 (Boyer et
al., 1999). An in situ hybridization study of TGF-h3
expression during heart development showed little or no
TGF-h in the myocardium or endocardium of the AV region
before stage 14 (Nakajima et al., 1998). Ghosh and Brauer
(1996) found latent TGF-h to be widely distributed in the
ECM of stage 14–16 hearts, suggesting a role for the post-
translational regulation of TGF-h activity in cushion mes-
enchyme formation. Ramsdell and Markwald (1997), using
AV explants from stage 13+ to 14 embryos in a collagen gel
EMT assay, concluded that processing of latent to active
TGF-h3 does not occur until stage 15. Accordingly, we used
AV explants from embryonic hearts of stages 15–16, and
quantified the change in cellular morphology to spindle
shape as the indicator of successful TGF-h3-mediated EMT
in vitro. In addition, other experiments using embryonic
hearts of same stages were designed to examine, in parallel,
the mechanism of release of active TGF-h3 from latency
during AV canal EMT.
We have shown that inhibition of plasmin activity by
a2AP profoundly suppresses EMT in vitro, and results in the
absence of detectable active TGF-h3 in the medium of
explanted heart cultures. Inhibition of annexin II-mediated
activation of plasminogen by tPA also results in a significant
decrease in the conversion to spindle-shaped, mesenchymal
phenotype (50%, Fig. 6) and undetectable active TGF-h3,
as well as a 50% reduction of TGF-h3 bioactivity in
medium conditioned by heart explant cultures. Taken to-
gether, these results suggest that annexin II-mediated plas-
min generation activates TGF-h3 during AV canal EMT,
and that cell-surface annexin II may play a role in the
normal development of AV valves. However, our results do
not show a complete inhibition of anti-annexin II IgG-mediated plasminogen activation, EMT or TGF-h bioactiv-
ity. This suggests that perhaps other mechanisms of TGF-h
activation could be involved (Annes et al., 2003), or that
different proteolytic systems such as uPA and MMPs might
interact in a concerted manner to generate plasmin-mediated
proteolytic activity during AV canal EMT.
As the expression pattern of both latent TGF-h in the
heart and annexin-II-mediated proteolytic activity in the
endocardium appears to be quite generalized, the final
subset of endocardial cells that undergo AV canal EMT
(Wunsch et al., 1994), is probably defined by the restricted
expression of type III TGF-h receptor (Brown et al., 1999).
Although the biological significance of the different TGF-h
receptors and how they may interact differentially with
TGF-h ligands during development are largely unknown,
the restricted expression of TGF-h receptors appears to be a
critical factor localizing the effect of TGF-h ligand-mediat-
ed signaling (Wrana et al., 1994). Co-localization of specific
TGF-h receptors on endocardial cells could thus be the
final, essential determinant of EMT dependent upon TGF-h
signaling.
Proteolytic activity, confined not only to the initial subset
of transforming cells, but also present on the surface of
surrounding endocardial cells, could help to propagate the
ripple effect of TGF-h3-mediated homogenetic induction
that occurs during cushion formation (Ramsdell and Mark-
wald, 1997). Thus, EEC-surface annexin II-mediated plas-
min generation could be involved in the autocrine/paracrine
loop of TGF-h3 activation during AV canal EMT, playing a
critical role in achieving the threshold amount of cushion
tissue required for normal valvular development. Addition-
ally, more widespread distribution of surface plasmin pro-
teolytic capability could enable neighboring cells to migrate
laterally and maintain the continuity of the endocardium, by
closing the spaces produced by invading mesenchymally
transformed cells.
TGF-h3 has also been shown to up-regulate expres-
sion of MMP2 and MT1-MMP in the context of AV
canal EMT (Song et al., 2000). A recent study showed
that plasmin could activate proMMP-2 in the presence of
MT1-MMP (Monea et al., 2002), suggesting broad sub-
strate specificity for plasmin activity. Plasmin can also
activate MMPs-1 and -3, and MMP-3, in turn, activates
MMP-9 (Loskutoff and Quigley, 2000; Ramos-DeSimone
et al., 1999). In addition, secretion of active TGF-h is
down-regulated by plasminogen activator inhibitor-1
(PAI-1), a specific inhibitor in the plasmin/plasminogen
system, as part of a self-regulating system (Sato et al.,
1990). Although, to date, the enzymes of the serine and
metalloproteinase families have not been fully character-
ized in the avian species, it can be hypothesized from the
available data (Hahn-Dantona et al., 2000; Johnson et al.,
1997) that the enzyme systems would be similar in
nature. In summary, these data suggest that regulated
plasmin activity could play an important role in activa-
tion of differentiation factors, and in initiating a cascade
S. Krishnan et al. / Developmental Biology 265 (2004) 140–154152of metalloproteinase activity during critical developmental
processes.
In this context, normal cardiogenesis in mice deficient
in plasminogen, plasminogen activators (Bugge et al.,
1995), or MMPs (Vu and Werb, 2000), could be consid-
ered as evidence that redundant mechanisms for plasmin
production are present in the developing embryo (Leo-
nardsson et al., 1995). Our in vitro data suggest that
techniques other than the creation of transgenic mice,
such as the somatic transgenic method, could be used to
ascertain the significance of genes of interest, particularly
in later developmental process such as organogenesis
(Hyer and Mikawa, 1997). In addition, mouse embryos
deficient for TGF-h3 do not have cardiac phenotypes
(Kaartinen et al., 1995). In TGF-h2/ embryos, the most
significant cardiac defect is related to OT development,
even though AV cushion formation is abnormal (Sanford
et al., 1997). These data, furthermore, point toward the
interspecies variation in TGF-h requirement during avian
and mouse endocardial cushion development.
In conclusion, we propose a model in which TGF-h3,
activated by annexin II-mediated plasmin generation, regu-
lates the differentiation of endocardial cells to spindle-
shaped mesenchymal cells. Up-regulation of MMPs, in-
duced by TGF-h3, could possibly occur downstream of this
event. Furthermore, annexin II-mediated plasmin activity
could also be involved in the activation of proMMPs,
permitting transformed mesenchymal cells, which retain
annexin II expression, to degrade and invade surrounding
ECM. TGF-h3 activation could, in turn, be regulated by a
negative feedback loop involving inhibitors of plasminogen
activation. Thus, multiple systems of proteases, morpho-
gens, and growth factors probably interact in a dynamic
fashion during the differentiation of endocardial cells and
the consequent remodeling of tissue and ECM during
normal development of the AV valves of the heart.Acknowledgments
We thank Dr. Andy Jacovina for excellent technical
guidance and training. We are grateful to Dr. Volker Gerke
(University of Muenster) for providing chick annexin II
cDNA and Dr. Takashi Mikawa for chick GAPDH probe.
We are indebted to Dr. Jeanette Hyer and Dr. Victoria
Ballard, for assistance and training in working with chick
embryos. We acknowledge Dr. Lynda Pierini for guidance
with analytical optical microscopy techniques, Leona
Cohen-Gould for use and training of confocal microscopy,
and Stacey Stanislaw, University of Arizona, for his
technical advice and insightful comments. We thank Drs.
Takashi Mikawa and Lynda Pierini for their critical reading
of the manuscript. This study was funded by MOD 6-FY00-
169 and HL 42493, HL 46403, HL 58981 to K.A.H., T32
GM07308 to J.P.A., and CA34282, CA78422 to D.B.R.References
Abe, M., Harpel, J.G., Metz, C.N., Nunes, I., Loskutoff, D.J., Rifkin, D.B.,
1994. An assay for transforming growth factor-beta using cells trans-
fected with a plasminogen activator inhibitor-1 promoter-luciferase con-
struct. Anal. Biochem. 216, 276–284.
Alexander, S.M., Jackson, K.J., Bushnell, K.M., McGuire, P.G., 1997.
Spatial and temporal expression of the 72-kDa type IV collagenase
(MMP-2) correlates with development and differentiation of valves in
the embryonic avian heart. Dev. Dyn. 209, 261–268.
Annes, J.P., Munger, J.S., Rifkin, D.B., 2003. Making sense of latent
TGFbeta activation. J. Cell Sci. 116, 217–224.
Barcellos-Hoff, M.H., Ehrhart, E.J., Kalia, M., Jirtle, R., Flanders, K.,
Tsang, M.L., 1995. Immunohistochemical detection of active transform-
ing growth factor-beta in situ using engineered tissue. Am. J. Pathol.
147, 1228–1237.
Bernanke, D.H., Markwald, R.R., 1982. Migratory behavior of cardiac
cushion tissue cells in a collagen-lattice culture system. Dev. Biol.
91 (2), 235–245.
Bolender, D.L., Seliger, W.G., Markwald, R.R., Brauer, P.R., 1981. Struc-
tural analysis of extracellular matrix prior to the migration of cephalic
neural crest cells. Scanning Electron Microsc., 285–296.
Boyer, A.S., Runyan, R.B., 2001. TGFbeta type III and TGFbeta type II
receptors have distinct activities during epithelial –mesenchymal cell
transformation in the embryonic heart. Dev. Dyn. 221 (4), 454–459.
Boyer, A.S., Ayerinskas, I.I., Vincent, E.B., McKinney, L.A., Weeks, D.L.,
Runyan, R.B., 1999. TGFbeta2 and TGFbeta3 have separate and se-
quential activities during epithelial–mesenchymal cell transformation
in the embryonic heart. Dev. Biol. 208, 530–545.
Brauer, P.R., Yee, J.A., 1993. Cranial neural crest cells synthesize and
secrete a latent form of transforming growth factor beta that can be
activated by neural crest cell proteolysis. Dev. Biol. 155, 281–285.
Brown, C.B., Boyer, A.S., Runyan, R.B., Barnett, J.V., 1999. Requirement
of type III TGF-beta receptor for endocardial cell transformation in the
heart. Science 283 (5410), 2080–2082.
Bugge, T.H., Flick, M.J., Daugherty, C.C., Degen, J.L., 1995. Plasminogen
deficiency causes severe thrombosis but is compatible with develop-
ment and reproduction. Genes Dev. 9 (7), 794–807.
Camenisch, T.D., Molin, D.G., Person, A., Runyan, R.B., Gittenberger-de
Groot, A.C., McDonald, J.A., Klewer, S.E., 2002. Temporal and distinct
TGFbeta ligand requirements during mouse and avian endocardial cush-
ion morphogenesis. Dev. Biol. 248 (1), 170–181.
Cano, A., Perez-Moreno, M.A., Rodrigo, I., Locascio, A., Blanco, M.J., del
Barrio, M.G., Portillo, F., Nieto, M.A., 2000. The transcription factor
snail controls epithelial–mesenchymal transitions by repressing E-cad-
herin expression. Nat. Cell Biol. 2, 76–83.
Carter, C., Howlett, A.R., Martin, G.S., Bissell, M.J., 1986. The tyrosine
phosphorylation substrate p36 is developmentally regulated in embry-
onic avian limb and is induced in cell culture. J. Cell Biol. 103,
2017–2024.
Cesarman, G.M., Guevara, C.A., Hajjar, K.A., 1994. An endothelial cell
receptor for plasminogen/tissue plasminogen activator (t-PA): II. An-
nexin II-mediated enhancement of t-PA-dependent plasminogen activa-
tion. J. Biol. Chem. 269, 21198–21203.
Chacko, G., Ling, Q., Hajjar, K.A., 1998. Induction of acute translational
response genes by homocysteine. Elongation factors-1alpha, -beta, and
-delta. J. Biol. Chem. 273, 19840–19846.
Collen, D., Lijnen, H.R., 1986. The fibrinolytic system in man. Crit. Rev.
Oncol. Hematol. 4, 249–301.
de la Cruz, M.V., Markwald, R.R., Krug, E.L., Rumenoff, L., Sanchez,
G.C., Sadowinski, S., Galicia, T.D., Gomez, F., Salazar, G.M., Villavi-
cencio, G.L., Reyes, A.L., Moreno-Rodriguez, R.A., 2001. Living mor-
phogenesis of the ventricles and congenital pathology of their
component parts. Cardiol. Young 11, 588–600.
Ghosh, S., Brauer, P.R., 1996. Latent transforming growth factor-beta is
present in the extracellular matrix of embryonic hearts in situ. Dev. Dyn.
205, 126–134.
S. Krishnan et al. / Developmental Biology 265 (2004) 140–154 153Gorny, K.N., Brauer, P.R., 1999. Urokinase regulates embryonic cardiac
cushion cell migration without converting plasminogen. Anat. Rec. 256,
269–278.
Hahn-Dantona, E.A., Aimes, R.T., Quigley, J.P., 2000. The isolation, char-
acterization, and molecular cloning of a 75-kDa gelatinase B-like en-
zyme, a member of the matrix metalloproteinase (MMP) family. An
avian enzyme that is MMP-9-like in its cell expression pattern but
diverges from mammalian gelatinase B in sequence and biochemical
properties. J. Biol. Chem. 275 (52), 40827–40838.
Haines, L., Currie, P.D., 2001. Morphogenesis and evolution of vertebrate
appendicular muscle. J. Anat. 199, 205–209.
Hajjar, K.A., 1995. Cellular receptors in the regulation of plasmin gener-
ation. Thromb. Haemost. 74, 294–301.
Hajjar, K.A., Krishnan, S., 1999. Annexin II: a mediator of the plasmin/
plasminogen activator system. Trends Cardiovasc. Med. 9, 128–138.
Hajjar, K.A., Harpel, P.C., Jaffe, E.A., Nachman, R.L., 1986. Binding of
plasminogen to cultured human endothelial cells. J. Biol. Chem. 261,
11656–11662.
Hajjar, K.A., Jacovina, A.T., Chacko, J., 1994. An endothelial cell receptor
for plasminogen/tissue plasminogen activator: I. Identity with annexin
II. J. Biol. Chem. 269 (33), 21191–21197.
Hajjar, K.A., Mauri, L., Jacovina, A.T., Zhong, F., Mirza, U.A., Padovan,
J.C., Chait, B.T., 1998. Tissue plasminogen activator binding to the
annexin II tail domain. Direct modulation by homocysteine. J. Biol.
Chem. 273 (16), 9987–9993.
Hamburger, V., Hamilton, H.L., 1992. A series of normal stages in the
development of the chick embryo. 1951. Dev. Dyn. 195, 231–272.
Hamre, K.M., Chepenik, K.P., Goldowitz, D., 1995. The annexins: specific
markers of midline structures and sensory neurons in the developing
murine central nervous system. J. Comp. Neurol. 352, 421–435.
Hay, E.D., 1995. An overview of epithelio-mesenchymal transformation.
Acta Anat. (Basel) 154, 8–20.
Hay, E.D., Zuk, A., 1995. Transformations between epithelium and mes-
enchyme: normal, pathological, and experimentally induced. Am. J.
Kidney Dis. 26, 678–690.
Hyer, J., Mikawa, T., 1997. Retroviral techniques for studying organogen-
esis with a focus on heart development. Mol. Cell. Biochem. 172 (1–2),
23–35.
Jacovina, A.T., Zhong, F., Khazanova, E., Lev, E., Deora, A.B., Hajjar,
K.A., 2001. Neuritogenesis and the nerve growth factor-induced differ-
entiation of PC-12 cells requires annexin II-mediated plasmin genera-
tion. J. Biol. Chem. 276 (52), 49350–49358.
Johnson, A.L., Bridgham, J.T., Anthony, R.V., 1997. Expression of avian
urokinase and tissue-type plasminogen activator messenger ribonucleic
acid during follicle development and atresia. Biol. Reprod. 56, 581–588.
Kaartinen, V., Voncken, J.W., Shuler, C., Warburton, D., Bu, D., Heister-
kamp, N., Groffen, J., 1995. Abnormal lung development and cleft palate
in mice lacking TGF-beta3 indicates defects of epithelial–mesenchymal
interaction. Nat. Genet. 11 (4), 415–421.
Leitlein, J., Aulwurm, S., Waltereit, R., Naumann, U., Wagenknecht, B.,
Garten, W., Weller, M., Platten, M., 2001. Processing of immunosup-
pressive pro-TGF-beta 1,2 by human glioblastoma cells involves cyto-
plasmic and secreted furin-like proteases. J. Immunol. 166, 7238–7243.
Leonardsson, G., Peng, X.R., Liu, K., Nordstrom, L., Carmeliet, P.,
Mulligan, R., Collen, D., Ny, T., 1995. Ovulation efficiency is re-
duced in mice that lack plasminogen activator gene function: func-
tional redundancy among physiological plasminogen. Proc. Natl.
Acad. Sci. U. S. A. 92 (26), 12446–12450.
Little, C.D., Rongish, B.J., 1995. The extracellular matrix during heart
development. Experientia 51, 873–882.
Lochter, A., Galosy, S., Muschler, J., Freedman, N., Werb, Z., Bissell, M.J.,
1997. Matrix metalloproteinase stromelysin-1 triggers a cascade of
molecular alterations that leads to stable epithelial-to-mesenchymal
conversion and a premalignant phenotype in mammary epithelial cells.
J. Cell Biol. 139, 1861–1872.
Loskutoff, D.J., Quigley, J.P., 2000. PAI-1, fibrosis, and the elusive provi-
sional fibrin matrix. J. Clin. Invest. 106, 1441–1443.Lyons, R.M., Keski-Oja, J., Moses, H.L., 1988. Proteolytic activation of
latent transforming growth factor-beta from fibroblast-conditioned me-
dium. J. Cell Biol. 106 (5), 1659–1665.
Markwald, R.R., Fitzharris, T.P., Smith, W.N., 1975. Structural analysis of
endocardial cytodifferentiation. Dev. Biol. 42, 160–180.
Markwald, R.R., Fitzharris, T.P., Manasek, F.J., 1977. Structural develop-
ment of endocardial cushions. Am. J. Anat. 148, 85–119.
Markwald, R., Eisenberg, C., Eisenberg, L., Trusk, T., Sugi, Y., 1996.
Epithelial–mesenchymal transformations in early avian heart develop-
ment. Acta Anat. 156 (3), 173–186.
Mazzieri, R., Munger, J.S., Rifkin, D.B., 2000. Measurement of active
TGF-beta generated by cultured cells. Methods Mol. Biol. 142, 13–27.
McCormick, K.M., 2001. TGFbeta2 activation status during cardiac mor-
phogenesis. Dev. Dyn. 222, 17–25.
McGuire, P.G., Alexander, S.M., 1993. Inhibition of urokinase synthesis
and cell surface binding alters the motile behavior of embryonic
endocardial-derived mesenchymal cells in vitro. Development 118,
931–939.
McGuire, P.G., Orkin, R.W., 1992. Urokinase activity in the developing
avian heart: a spatial and temporal analysis. Dev. Dyn. 193, 24–33.
McKanna, J.A., Cohen, S., 1989. The EGF receptor kinase substrate p35 in
the floor plate of the embryonic rat CNS. Science 243, 1477–1479.
Monea, S., Lehti, K., Keski-Oja, J., Mignatti, P., 2002. Plasmin acti-
vates pro-matrix metalloproteinase-2 with a membrane-type 1 ma-
trix metalloproteinase-dependent mechanism. J. Cell. Physiol. 192,
160–170.
Munger, J.S., Harpel, J.G., Gleizes, P.E., Mazzieri, R., Nunes, I., Rifkin,
D.B., 1997. Latent transforming growth factor-beta: structural features
and mechanisms of activation. Kidney Int. 51, 1376–1382.
Nakajima, Y., Mironov, V., Yamagishi, T., Nakamura, H., Markwald, R.R.,
1997. Expression of smooth muscle alpha-actin in mesenchymal cells
during formation of avian endocardial cushion tissue: a role for trans-
forming growth factor beta3. Dev. Dyn. 209 (3), 296–309.
Nakajima, Y., Yamagishi, T., Nakamura, H., Markwald, R.R., Krug,
E.L., 1998. An autocrine function for transforming growth factor
(TGF)-beta3 in the transformation of atrioventricular canal endocar-
dium into mesenchyme during chick heart development. Dev. Biol.
194 (1), 99–113.
Nakajima, Y., Yamagishi, T., Yoshimura, K., Nomura, M., Nakamura, H.,
1999. Antisense oligodeoxynucleotide complementary to smooth muscle
alpha-actin inhibits endothelial –mesenchymal transformation during
chick cardiogenesis. Dev. Dyn. 216 (4–5), 489–498.
Pardanaud, L., Altmann, C., Kitos, P., Dieterlen-Lievre, F., Buck, C.A.,
1987. Vasculogenesis in the early quail blastodisc as studied with a
monoclonal antibody recognizing endothelial cells. Development 100,
339–349.
Pierini, L.M., Doering, T.L., 2001. Spatial and temporal sequence of cap-
sule construction in Cryptococcus neoformans. Mol. Microbiol. 41,
105–115.
Plesner, T., Ralfkiaer, E., Wittrup, M., Johnsen, H., Pyke, C., Pedersen,
T.L., Hansen, N.E., Dano, K., 1994. Expression of the receptor for
urokinase-type plasminogen activator in normal and neoplastic blood
cells and hematopoietic tissue. Am. J. Clin. Pathol. 102, 835–841.
Pollanen, J., Saksela, O., Salonen, E.M., Andreasen, P., Nielsen, L., Dano,
K., Vaheri, A., 1987. Distinct localizations of urokinase-type plasmino-
gen activator and its type 1 inhibitor under cultured human fibroblasts
and sarcoma cells. J. Cell Biol. 104, 1085–1096.
Potts, J.D., Dagle, J.M., Walder, J.A., Weeks, D.L., Runyan, R.B., 1991.
Epithelial–mesenchymal transformation of embryonic cardiac endothe-
lial cells is inhibited by a modified antisense oligodeoxynucleotide to
transforming growth factor beta 3. Proc. Natl. Acad. Sci. U. S. A. 88,
1516–1520.
Ramos-DeSimone, N., Hahn-Dantona, E., Sipley, J., Nagase, H., French,
D.L., Quigley, J.P., 1999. Activation of matrix metalloproteinase-9
(MMP-9) via a converging plasmin/stromelysin-1 cascade enhances
tumor cell invasion. J. Biol. Chem. 274, 13066–13076.
Ramsdell, A.F., Markwald, R.R., 1997. Induction of endocardial cushion
S. Krishnan et al. / Developmental Biology 265 (2004) 140–154154tissue in the avian heart is regulated, in part, by TGFbeta-3-mediated
autocrine signaling. Dev. Biol. 188, 64–74.
Rezaee, M., Isokawa, K., Halligan, N., Markwald, R.R., Krug, E.L., 1993.
Identification of an extracellular 130-kDa protein involved in early
cardiac morphogenesis. J. Biol. Chem. 268 (19), 14404–14411.
Rifkin, D.B., Mazzieri, R., Munger, J.S., Noguera, I., Sung, J.,
1999. Proteolytic control of growth factor availability. APMIS
107, 80–85.
Runyan, R.B., Markwald, R.R., 1983. Invasion of mesenchyme into three-
dimensional collagen gels: a regional and temporal analysis of interac-
tion in embryonic heart tissue. Dev. Biol. 95, 108–114.
Sanford, L.P., Ormsby, I., Gittenberger-de Groot, A.C., Sariola, H., Fried-
man, R., Boivin, G.P., Cardell, E.L., Doetschman, T., 1997. TGFbeta2
knockout mice have multiple developmental defects that are non-
overlapping with other TGFbeta knockout phenotypes. Development
124 (13), 2659–2670.
Sato, Y., Rifkin, D.B., 1989. Inhibition of endothelial cell movement by
pericytes and smooth muscle cells: activation of a latent transforming
growth factor-beta 1-like molecule by plasmin during co-culture. J. Cell
Biol. 109, 309–315.
Sato, Y., Tsuboi, R., Lyons, R., Moses, H., Rifkin, D.B., 1990. Character-
ization of the activation of latent TGF-beta by co-cultures of endothe-
lial cells and pericytes or smooth muscle cells: a self-regulating system.
J. Cell Biol. 111 (2), 757–763.
Skalli, O., Ropraz, P., Trzeciak, A., Benzonana, G., Gillessen, D., Gabbia-
ni, G., 1986. A monoclonal antibody against alpha-smooth muscle
actin: a new probe for smooth muscle differentiation. J. Cell Biol.
103, 2787–2796.
Song, W., Majka, S.M., McGuire, P.G., 1999. Hepatocyte growth factor
expression in the developing myocardium: evidence for a role in the
regulation of the mesenchymal cell phenotype and urokinase expres-
sion. Dev. Dyn. 214 (1), 92–100.
Song, W., Jackson, K., McGuire, P.G., 2000. Degradation of type IV col-
lagen by matrix metalloproteinases is an important step in the epithe-lial –mesenchymal transformation of the endocardial cushions. Dev.
Biol. 227 (2), 606–617.
Stern, C.D., 1998. Detection of multiple gene products simultaneously by
in situ hybridization and immunohistochemistry in whole mounts of
avian embryos. Curr. Top. Dev. Biol. 36, 223–243.
Taipale, J., Miyazono, K., Heldin, C.H., Keski-Oja, J., 1994. Latent trans-
forming growth factor-beta 1 associates to fibroblast extracellular ma-
trix via latent TGF-beta binding protein. J. Cell Biol. 124, 171–181.
Thery, C., Stern, C.D., 1996. Roles of kringle domain-containing serine
proteases in epithelial–mesenchymal transitions during embryonic de-
velopment. Acta Anat. (Basel) 156, 162–172.
Thiery, J.P., 2002. Epithelial–mesenchymal transitions in tumour progres-
sion. Nat. Rev. Cancer 2, 442–454.
Vu, T.H., Werb, Z., 2000. Matrix metalloproteinases: effectors of develop-
ment and normal physiology. Genes Dev. 14 (17), 2123–2133.
Wakefield, L.M., Smith, D.M., Flanders, K.C., Sporn, M.B., 1988. Latent
transforming growth factor-beta from human platelets. A high molec-
ular weight complex containing precursor sequences. J. Biol. Chem.
263, 7646–7654.
Wrana, J.L., Attisano, L., Wieser, R., Ventura, F., Massague, J., 1994.
Mechanism of activation of the TGF-beta receptor. Nature 370 (6488),
341–347.
Wunsch, A.M., Little, C.D., Markwald, R.R., 1994. Cardiac endothelial
heterogeneity defines valvular development as demonstrated by the
diverse expression of JB3, an antigen of the endocardial cushion tissue.
Dev. Biol. 165 (2), 585–601.
Yamagishi, T., Nakajima, Y., Miyazono, K., Nakamura, H., 1999. Bone
morphogenetic protein-2 acts synergistically with transforming growth
factor-beta3 during endothelial–mesenchymal transformation in the de-
veloping chick heart. J. Cell. Physiol. 180, 35–45.
Zavadil, J., Bitzer, M., Liang, D., Yang, Y.C., Massimi, A., Kneitz, S.,
Piek E., Bottinger, E.P., 2001. Genetic programs of epithelial cell plas-
ticity directed by transforming growth factor-beta. Proc. Natl. Acad.
Sci. U. S. A. 98, 6686–6691.
